Steady Growth of 3% CAGR in Acne Drugs Market Observed to 2020

Share this news:

The Global Acne Drugs Market 2016 – 2020 research report presents a detailed segmentation of the global acne drugs market by drug class, by route of administration (topical, and oral), and by type (prescription and OTC).

The market research analyst predicts the global acne drugs market to grow steadily at a CAGR of approximately 3% during the forecast period. The occurrence of acne due to lifestyle changes is the primary driver for the market. Sedentary lifestyle and unhealthy food habits lead to hormonal problems, which trigger the development of acne. Lack of sleep, emotional and work-related stress, smoking, drug abuse, and alcohol consumption are major triggers for the occurrence of acne among teenagers and adults.

The complete report on acne drugs market spreads across 84 pages, analysis 4 major market leaders and provides 46 data exhibits is available at http://www.reportsnreports.com/reports/443000-global-acne-drugs-market-2016-2020.html.

The rise in disposable income has encouraged consumers, especially the middle-class income group, to spend more on personal care products. The rising awareness of acne and the current and upcoming treatments is expected to drive the acne drugs market through the forecast period. Women particularly, play a crucial role in this market as the demand generated by them influences the market growth considerably.

According to the report, many acne drugs are available in the market. However, these drugs provide symptomatic treatment and do not cure the condition. Symptomatic treatment involves the reduction of acne lesions by almost 50% and not the suppression of acne recurrence. Most people with acne use isotretinoin to relieve their condition. However, this drug has teratogenic effects and cannot be prescribed for pregnant women.

Segmentation by drug class and analysis of the acne drugs market are Antibiotics, Anti-inflammatory drugs, Antimicrobial, Combination medications, Hormonal agents, Oral retinoid and Topical retinoid.

Acne medication depends on the skin type and the severity of the condition. For instance, oral retinoid agents are considered as the appropriate treatment for severe acne. These drugs help prevent excessive oil production, bacterial acne growth, and inflammation.

Segmentation by method of administration and analysis of the acne drugs market are Topical are Oral.
The topical drugs segment dominated the market during 2015, accounting for a market share of around 54%. Ease of application, low systemic side-effects, and easy availability of these products are the primary drivers for the growth of this segment. Order a Copy of Global Acne Drugs Market 2016-2020 Report at http://www.reportsnreports.com/purchase.aspx?name=443000.

Segmentation by type and analysis of the acne drugs market are Prescription drugs and OTC drugs.
Prescription drugs dominated the market during 2015 due to the increased awareness about acne and the treatments options, especially in the developed countries. For instance, Epiduo, Benzaclin, and Duac are some of the popular acne prescription drugs available in the market.

Segmentation by geography and analysis of the acne drugs market are Americas, APAC and EMEA
The Americas accounted for around 90% of the market share during 2015 but is expected to witness a decline in sales during the forecast period. Lifestyle changes, increase in awareness programs about acne, and availability of acne treatment options are the primary drivers for market growth in this region.

Competitive landscape and key vendors
The global acne drugs market is dominated by key vendors. The availability of OTC drugs and the preference for alternative therapies for treating acne has been restricting the sales of branded acne products. Vendors in this market are anticipated to invest heavily on R&D during the forecast period.

The leading vendors in the market are -
• Allergan
• Galderma
• Stiefel
• Valeant

The other prominent vendors in the market include AndroScience, Anterios, Aqua Pharmaceuticals, Astellas, Bayer HealthCare, BioPharmX, Celtaxsys, Cipher Pharmaceuticals, COSMO Pharmaceuticals, Dermira, Elorac, F.Hoffmann-La Roche, Foamix, GlaxoSmithKline, Guthy-Renker, Helix BioMedix, Hygeia Therapeutics, Johnson & Johnson, Meda, Mylan, Novan, Oculus Innovative Sciences, Paratek Pharmaceuticals, Photocure, Promius Pharma, Ranbaxy, Reckitt Benckiser, Skinvisible Pharmaceuticals, Teva, Versapharm, and XBiotech.

Further, the report states that though the available drugs are effective in alleviating acne, they have certain harmful side effects. Dryness, burning, itching, flaking, irritation, and slight puffiness of the skin are some of the side effects of topical acne drugs. Oral drugs can also cause side effects. Solodyn (minocycline), an oral acne drug, has many side effects, and its administration requires medical supervision.

Explore other new reports by Infiniti Research at http://www.reportsnreports.com/publisher/infiniti-research-limited/.

About US:
ReportsnReports.com is an online market research reports library of 500,000+ reports and in-depth studies of 5000+ micro markets. Call +1 888 391 5441 with industry research requirements or email, the details on sales at reportsandreports.com.

Contact Info:
Name: Ritesh Tiwari
Email: Send Email
Organization: ReportsnReports.com
Phone: + 1 888 391 5441
Website: http://www.reportsnreports.com/reports/443000-global-acne-drugs-market-2016-2020.html

Release ID: 97580

CONTACT ISSUER
Name: Ritesh Tiwari
Email: Send Email
Organization: ReportsnReports.com
SUBSCRIBE FOR MORE